aluates Reports

$ 0.0

Automative

Global Sickle Cell Anemia Therapeutics Market Research Report 2026

Published Date: 2026-03-04

Report Code: QYRE-Auto-26Q12719

Global Sickle Cell Anemia Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Sickle Cell Anemia Therapeutics Market Research Report 2026

Code: QYRE-Auto-26Q12719

Report

2026-03-04

Pages:119

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gamida Cell

GlycoMimetics

Pfizer Inc

Novartis

Bluebird bio

Prolong Pharmaceuticals

Modus Therapeutics

Sangamo BioSciences

Bioverativ

Imara

Ironwood Pharmaceuticals

Emmaus Medical

Novo Nordisk

CRISPR Therapeutics

Theravia

Sickle Cell Anemia Therapeutics Market Size

The global Sickle Cell Anemia Therapeutics market was valued at US$ 4623 million in 2025 and is anticipated to reach US$ 11220 million by 2032, at a CAGR of 13.7% from 2026 to 2032.

Sickle Cell Anemia Therapeutics Market

Sickle cell disease (SCD) is a chronic, inherited blood disorder caused by a mutation in the beta-globin gene, leading to the production of abnormal hemoglobin called sickle hemoglobin (HbS). Under low-oxygen conditions, HbS polymerizes, causing red blood cells to assume a rigid, sickle shape. These deformed cells are prone to hemolysis and can block blood vessels, resulting in pain, anemia, and organ damage. Therapeutic approaches include pharmacological treatments (e.g., hydroxyurea, L-glutamine), gene therapy, hematopoietic stem cell transplantation, and supportive care.

Global Sickle Cell Anemia Therapeutics key players include Emmaus Medical, Theravia, Gamida Cell, GlycoMimetics, etc. Americas is the largest market, with a share about 55%, followed by Europe, and Middle East & Africa, both have a share over 35 percent. In terms of product, Blood Transfusion is the largest segment, with a share over 35%. And in terms of application, the largest application is Child, followed by Adult.The therapeutic landscape for sickle cell disease is rapidly evolving, with major pharmaceutical players (e.g., Pfizer, Novartis, Novo Nordisk) investing alongside specialized biotech firms (e.g., Bluebird Bio, CRISPR Therapeutics, Imara, Emmaus Medical). Approved treatments range from small-molecule agents like L-glutamine (Emmaus) to gene-based curative approaches such as Bluebird’s Zynteglo and CRISPR/Vertex’s Casgevy, marking a shift toward durable, potentially one-time interventions. Future development will prioritize expanding patient access to gene therapies, addressing long-term safety, and improving conditioning regimens for stem cell transplantation. Novel approaches, including anti-adhesion therapies (GlycoMimetics), nitric oxide modulators (Prolong), and macrophage-targeted solutions (Modus), are diversifying the pipeline. With ongoing clinical innovation and supportive regulatory momentum, the field is transitioning from symptomatic relief to functional cures, especially for underserved global populations.

This report delivers a comprehensive overview of the global Sickle Cell Anemia Therapeutics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sickle Cell Anemia Therapeutics. The Sickle Cell Anemia Therapeutics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sickle Cell Anemia Therapeutics market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sickle Cell Anemia Therapeutics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sickle Cell Anemia Therapeutics Market Report

Report Metric	Details
Report Name	Sickle Cell Anemia Therapeutics Market
Accounted market size in 2025	US$ 4623 million
Forecasted market size in 2032	US$ 11220 million
CAGR	13.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Blood Transfusion Pharmacotherapy Bone Marrow Transplant
Segment by Application	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Emmaus Medical, Theravia, Pfizer, Novartis, Bluebird Bio, Novo Nordisk, Gamida Cell, CRISPR Therapeutics, GlycoMimetics, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sickle Cell Anemia Therapeutics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Sickle Cell Anemia Therapeutics Market growing?

Ans: The Sickle Cell Anemia Therapeutics Market witnessing a CAGR of 13.7% during the forecast period 2026-2032.

What is the Sickle Cell Anemia Therapeutics Market size in 2032?

Ans: The Sickle Cell Anemia Therapeutics Market size in 2032 will be US$ 11220 million.

What is the Sickle Cell Anemia Therapeutics Market share by type?

Ans: In terms of product, Blood Transfusion is the largest segment, with a share over 35%.

Who are the main players in the Sickle Cell Anemia Therapeutics Market report?

Ans: The main players in the Sickle Cell Anemia Therapeutics Market are Emmaus Medical, Theravia, Pfizer, Novartis, Bluebird Bio, Novo Nordisk, Gamida Cell, CRISPR Therapeutics, GlycoMimetics, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Sickle Cell Anemia Therapeutics Market report?

Ans: The Applications covered in the Sickle Cell Anemia Therapeutics Market report are Child, Adult

What are the Type segmentation covered in the Sickle Cell Anemia Therapeutics Market report?

Ans: The Types covered in the Sickle Cell Anemia Therapeutics Market report are Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Blood Transfusion

1.2.3 Pharmacotherapy

1.2.4 Bone Marrow Transplant

1.3 Market by Application

1.3.1 Global Sickle Cell Anemia Therapeutics Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Child

1.3.3 Adult

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2021–2032)

2.2 Global Sickle Cell Anemia Therapeutics Growth Trends by Region

2.2.1 Global Sickle Cell Anemia Therapeutics Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2021–2026)

2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2027–2032)

2.3 Sickle Cell Anemia Therapeutics Market Dynamics

2.3.1 Sickle Cell Anemia Therapeutics Industry Trends

2.3.2 Sickle Cell Anemia Therapeutics Market Drivers

2.3.3 Sickle Cell Anemia Therapeutics Market Challenges

2.3.4 Sickle Cell Anemia Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue

3.1.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue (2021–2026)

3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2021–2026)

3.2 Global Top Sickle Cell Anemia Therapeutics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Sickle Cell Anemia Therapeutics Revenue

3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio

3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2025

3.5 Global Key Players of Sickle Cell Anemia Therapeutics Head Offices and Areas Served

3.6 Global Key Players of Sickle Cell Anemia Therapeutics, Products and Applications

3.7 Global Key Players of Sickle Cell Anemia Therapeutics, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Sickle Cell Anemia Therapeutics Breakdown Data by Type

4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2021–2026)

4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2027–2032)

5 Sickle Cell Anemia Therapeutics Breakdown Data by Application

5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2021–2026)

5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Sickle Cell Anemia Therapeutics Market Size (2021–2032)

6.2 North America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)

6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2021–2032)

7.2 Europe Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)

7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size (2021–2032)

8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2021–2026)

8.4 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Sickle Cell Anemia Therapeutics Market Size (2021–2032)

9.2 Latin America Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)

9.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size (2021–2032)

10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2021–2026)

10.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Emmaus Medical

11.1.1 Emmaus Medical Company Details

11.1.2 Emmaus Medical Business Overview

11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction

11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.1.5 Emmaus Medical Recent Development

11.2 Theravia

11.2.1 Theravia Company Details

11.2.2 Theravia Business Overview

11.2.3 Theravia Sickle Cell Anemia Therapeutics Introduction

11.2.4 Theravia Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.2.5 Theravia Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Sickle Cell Anemia Therapeutics Introduction

11.3.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.3.5 Pfizer Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Sickle Cell Anemia Therapeutics Introduction

11.4.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.4.5 Novartis Recent Development

11.5 Bluebird Bio

11.5.1 Bluebird Bio Company Details

11.5.2 Bluebird Bio Business Overview

11.5.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction

11.5.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.5.5 Bluebird Bio Recent Development

11.6 Novo Nordisk

11.6.1 Novo Nordisk Company Details

11.6.2 Novo Nordisk Business Overview

11.6.3 Novo Nordisk Sickle Cell Anemia Therapeutics Introduction

11.6.4 Novo Nordisk Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.6.5 Novo Nordisk Recent Development

11.7 Gamida Cell

11.7.1 Gamida Cell Company Details

11.7.2 Gamida Cell Business Overview

11.7.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction

11.7.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.7.5 Gamida Cell Recent Development

11.8 CRISPR Therapeutics

11.8.1 CRISPR Therapeutics Company Details

11.8.2 CRISPR Therapeutics Business Overview

11.8.3 CRISPR Therapeutics Sickle Cell Anemia Therapeutics Introduction

11.8.4 CRISPR Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.8.5 CRISPR Therapeutics Recent Development

11.9 GlycoMimetics

11.9.1 GlycoMimetics Company Details

11.9.2 GlycoMimetics Business Overview

11.9.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction

11.9.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.9.5 GlycoMimetics Recent Development

11.10 Prolong Pharmaceuticals

11.10.1 Prolong Pharmaceuticals Company Details

11.10.2 Prolong Pharmaceuticals Business Overview

11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction

11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.10.5 Prolong Pharmaceuticals Recent Development

11.11 Modus Therapeutics

11.11.1 Modus Therapeutics Company Details

11.11.2 Modus Therapeutics Business Overview

11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction

11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.11.5 Modus Therapeutics Recent Development

11.12 Sangamo Biosciences

11.12.1 Sangamo Biosciences Company Details

11.12.2 Sangamo Biosciences Business Overview

11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction

11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.12.5 Sangamo Biosciences Recent Development

11.13 Bioverativ

11.13.1 Bioverativ Company Details

11.13.2 Bioverativ Business Overview

11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction

11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.13.5 Bioverativ Recent Development

11.14 Imara

11.14.1 Imara Company Details

11.14.2 Imara Business Overview

11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction

11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.14.5 Imara Recent Development

11.15 Ironwood Pharmaceuticals

11.15.1 Ironwood Pharmaceuticals Company Details

11.15.2 Ironwood Pharmaceuticals Business Overview

11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction

11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2021–2026)

11.15.5 Ironwood Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gamida Cell

GlycoMimetics

Pfizer Inc

Novartis

Bluebird bio

Prolong Pharmaceuticals

Modus Therapeutics

Sangamo BioSciences

Bioverativ

Imara

Ironwood Pharmaceuticals

Emmaus Medical

Novo Nordisk

CRISPR Therapeutics

Theravia

List of Tables

Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Blood Transfusion

Table 3. Key Players of Pharmacotherapy

Table 4. Key Players of Bone Marrow Transplant

Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2021–2026)

Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2027–2032)

Table 11. Sickle Cell Anemia Therapeutics Market Trends

Table 12. Sickle Cell Anemia Therapeutics Market Drivers

Table 13. Sickle Cell Anemia Therapeutics Market Challenges

Table 14. Sickle Cell Anemia Therapeutics Market Restraints

Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (US$ Million), 2021–2026

Table 16. Global Sickle Cell Anemia Therapeutics Market Share by Players (2021–2026)

Table 17. Global Top Sickle Cell Anemia Therapeutics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sickle Cell Anemia Therapeutics Revenue, 2025

Table 18. Ranking of Global Top Sickle Cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Sickle Cell Anemia Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Sickle Cell Anemia Therapeutics, Products and Applications

Table 22. Global Key Players of Sickle Cell Anemia Therapeutics, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (US$ Million), 2021–2026

Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2021–2026)

Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2027–2032)

Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (US$ Million), 2021–2026

Table 29. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2021–2026)

Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2027–2032)

Table 32. North America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (US$ Million), 2027–2032

Table 47. Emmaus Medical Company Details

Table 48. Emmaus Medical Business Overview

Table 49. Emmaus Medical Sickle Cell Anemia Therapeutics Product

Table 50. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 51. Emmaus Medical Recent Development

Table 52. Theravia Company Details

Table 53. Theravia Business Overview

Table 54. Theravia Sickle Cell Anemia Therapeutics Product

Table 55. Theravia Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 56. Theravia Recent Development

Table 57. Pfizer Company Details

Table 58. Pfizer Business Overview

Table 59. Pfizer Sickle Cell Anemia Therapeutics Product

Table 60. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 61. Pfizer Recent Development

Table 62. Novartis Company Details

Table 63. Novartis Business Overview

Table 64. Novartis Sickle Cell Anemia Therapeutics Product

Table 65. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 66. Novartis Recent Development

Table 67. Bluebird Bio Company Details

Table 68. Bluebird Bio Business Overview

Table 69. Bluebird Bio Sickle Cell Anemia Therapeutics Product

Table 70. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 71. Bluebird Bio Recent Development

Table 72. Novo Nordisk Company Details

Table 73. Novo Nordisk Business Overview

Table 74. Novo Nordisk Sickle Cell Anemia Therapeutics Product

Table 75. Novo Nordisk Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 76. Novo Nordisk Recent Development

Table 77. Gamida Cell Company Details

Table 78. Gamida Cell Business Overview

Table 79. Gamida Cell Sickle Cell Anemia Therapeutics Product

Table 80. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 81. Gamida Cell Recent Development

Table 82. CRISPR Therapeutics Company Details

Table 83. CRISPR Therapeutics Business Overview

Table 84. CRISPR Therapeutics Sickle Cell Anemia Therapeutics Product

Table 85. CRISPR Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 86. CRISPR Therapeutics Recent Development

Table 87. GlycoMimetics Company Details

Table 88. GlycoMimetics Business Overview

Table 89. GlycoMimetics Sickle Cell Anemia Therapeutics Product

Table 90. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 91. GlycoMimetics Recent Development

Table 92. Prolong Pharmaceuticals Company Details

Table 93. Prolong Pharmaceuticals Business Overview

Table 94. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product

Table 95. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 96. Prolong Pharmaceuticals Recent Development

Table 97. Modus Therapeutics Company Details

Table 98. Modus Therapeutics Business Overview

Table 99. Modus Therapeutics Sickle Cell Anemia Therapeutics Product

Table 100. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 101. Modus Therapeutics Recent Development

Table 102. Sangamo Biosciences Company Details

Table 103. Sangamo Biosciences Business Overview

Table 104. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product

Table 105. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 106. Sangamo Biosciences Recent Development

Table 107. Bioverativ Company Details

Table 108. Bioverativ Business Overview

Table 109. Bioverativ Sickle Cell Anemia Therapeutics Product

Table 110. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 111. Bioverativ Recent Development

Table 112. Imara Company Details

Table 113. Imara Business Overview

Table 114. Imara Sickle Cell Anemia Therapeutics Product

Table 115. Imara Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 116. Imara Recent Development

Table 117. Ironwood Pharmaceuticals Company Details

Table 118. Ironwood Pharmaceuticals Business Overview

Table 119. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product

Table 120. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (US$ Million), 2021–2026

Table 121. Ironwood Pharmaceuticals Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Sickle Cell Anemia Therapeutics Picture

Figure 2. Global Sickle Cell Anemia Therapeutics Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2025 vs 2032

Figure 4. Blood Transfusion Features

Figure 5. Pharmacotherapy Features

Figure 6. Bone Marrow Transplant Features

Figure 7. Global Sickle Cell Anemia Therapeutics Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2025 vs 2032

Figure 9. Child Case Studies

Figure 10. Adult Case Studies

Figure 11. Sickle Cell Anemia Therapeutics Report Years Considered

Figure 12. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2025 vs 2032

Figure 15. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2025

Figure 16. Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2025

Figure 18. North America Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)

Figure 20. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)

Figure 24. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Region (2021–2032)

Figure 32. China Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)

Figure 40. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Country (2021–2032)

Figure 44. Israel Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Sickle Cell Anemia Therapeutics Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 48. Theravia Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 49. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 50. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 51. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 52. Novo Nordisk Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 53. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 54. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 55. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 56. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 57. Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 58. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 59. Bioverativ Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 60. Imara Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 61. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2021–2026)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Therapy for Sickle Cell Disease Market Research Report 2024

Sickle Cell Anemia Testing Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemoglobinopathies Market Insights Forecast to 2030

Global Hemoglobinopathy Treatment Market Insights Forecast to 2030

Global Hemoglobinopathy Testing Services Market Insights Forecast to 2030

Global Hemoglobinopathy Drugs Market Insights Forecast to 2030

Global Sickle Cell Disease Diagnosis Market Insights Forecast to 2030

Myelodysplastic Syndrome MDS Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2025

Global Bench top HbA1c Analyzers Market Insights Forecast to 2030

Global Transfusion dependent Anemia Treatment Market Research Report 2025

Gaucher Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metachromatic Leukodystrophy Treatment Market Research Report 2025

Global Anemia Treatment Drugs Market Insights Forecast to 2030

Global Thalassemia Gene Test Kit Market Research Report 2024

Global Congenital Heart Diseases Market Research Report 2024

Global Direct to consumer Disease Risk and Health Genetic Test Market Insights Forecast to 2030

Global Chromatography Hemoglobin Testing Market Research Report 2024

Alpha Thalassemia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions